14 results
P
individuals with a history of higher weight
I/C
weight loss, binge eating
O
lower binge eating
P
lung disease, li, ipf
I/C
baicalin, no intervention
O
reduced inflammation, decreased apoptosis, protected against progression
P
patients with liver lesions
I/C
LI-RADS algorithm, original studies reporting probability of LR-M for HCC and non-HCC malignancy on MRI
O
pooled percentages of HCC and non-HCC malignancy for LR-M, sources of heterogeneity between reported results
P
Bulimia Nervosa
I/C
Pharmacotherapy, Cognitive Behavioural Therapy, Placebo
O
Remission, Binge Frequency, Treatment Response
P
Li QL, Yao MF, Cao RY, Zhao K, Wang XD
I/C
short dental implants, splinted and nonsplinted prostheses
O
survival rates
P
non-psychiatric subjects, psychiatric participants, anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), schizophrenia
I/C
intranasal OT (INOT), placebo
O
food intake, craving, anxiety or stress reduction
P
Individuals participating in blood flow restriction (BFR) training
I/C
BFR training, High-intensity resistance training (HIRT)
O
Muscular strength, hypertrophy, and endurance
P
red yeast rice preparations
I/C
RYR preparations, control treatments
O
adverse health outcomes
P
Orthodontic-surgical treatment patients
I/C
Conventional combined orthodontic-surgical treatment, No treatment or alternative treatments
O
Oral health-related quality of life
P
marginalized individuals
I/C
discrimination, non-marginalized individuals
O
eating disorder psychopathology